| Original language | English |
|---|---|
| Pages (from-to) | 266-267 |
| Number of pages | 2 |
| Journal | International Journal of Cardiology |
| Volume | 250 |
| DOIs | |
| State | Published - Jan 1 2018 |
Funding
Dr. Pepine receives support from the Gatorade Trust through funds distributed by the University of Florida, Department of Medicine; NIH/NHLBI--UFRCC for the Cardiovascular Cell Therapy Research Network and Training Core Supplement HL087366, Brain-Gut Microbiome-Immune Axis in Hypertension HL132448, and Angiotensin and Neuroimmune Activation in Hypertension HL033610; US Dept. of Defense CDRMP Ischemia-Intensive Medical Treatment Reduces Events in Women with Nonobstructive CAD PR161603; NIH NCATS—University of Florida Clinical and Translational Science UL1TR001427; and PCORnet-OneFlorida Clinical Research Consortium CDRN-1501-26,692.
| Funders | Funder number |
|---|---|
| Avedisian School of Medicine Department of Medicine | |
| Gatorade Trust | |
| NIH NCATS | |
| UFRCC | HL087366, HL132448 |
| Clinical and Translational Science Institute, University of Florida | UL1TR001427 |
| National Institutes of Health (NIH) | |
| U.S. Department of Defense | |
| National Heart, Lung, and Blood Institute (NHLBI) | |
| Florida AandM University and Florida State University |
Keywords
- Coronary heart disease
- hsTroponin I
- hsTroponin T
- Risk prediction
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Fingerprint
Dive into the research topics of 'High sensitivity cardiac troponin T and I and risk stratification of patients with stable CHD: Is it time to incorporate this in routine clinical practice?'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver